Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.21.2
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of fair value of impaired notes receivable
  Level September 30,
2021
December 31,
2020
Cash equivalents 2 $ 63,035  $ 177,912 
Marketable securities 2 $ 29,961  $ — 
Notes receivable impaired 3 $ —  $ 875